CSL CEO Paul Perreault Focuses on Patient-Centric Leadership in Pharma
Go back to CSL CEO Paul Perreault Focuses on Patient-Centric Leadership in Pharma| CARLISLE COMPANIES, Inc. (NYSE: CSL) | Delayed: 357.55 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $357.55 | 52 Week High | $114.49 | |||
| Open | $357.55 | 52 Week Low | $75.17 | |||
| Day High | $357.55 | P/E | 99.04 | |||
| Day Low | $357.55 | EPS | $3.61 | |||
| Volume | 2,348 | |||||
| (AMEX: CSLLY) | Delayed: 30.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.44 | 52 Week High | $45.60 | |||
| Open | $30.44 | 52 Week Low | $33.39 | |||
| Day High | $30.44 | P/E | N/A | |||
| Day Low | $30.44 | EPS | $0.00 | |||
| Volume | 3,500 | |||||
